RecruitingNCT05222100

Effect of Breast Implants om Mammography Screening

Sponsor

Vastra Gotaland Region

Enrollment

2,500 participants

Start Date

May 12, 2021

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Summary

The purpose of the study is to survey how many women have breast implants in the mammography screening population and the effect of implants on the number and type of examinations and on costs.

Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how breast implants affect the quality of mammogram images during routine breast cancer screening. It aims to determine whether implants make it harder to detect cancer on a mammogram. **You may be eligible if...** - You are a woman participating in a routine mammography (breast cancer) screening program **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMammography screening

Breast screening mammograms use X-rays to look for cancers that are too small to see or feel.

Locations(1)

Sahlgrenska university hospital

Gothenburg, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05222100

Related Trials

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

NCT06790693226 locations

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

NCT058799261238 locations

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

NCT072146624 locations

Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain

NCT070955691 location

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

NCT07062965384 locations